JP2024517931A5 - - Google Patents
Info
- Publication number
- JP2024517931A5 JP2024517931A5 JP2023569823A JP2023569823A JP2024517931A5 JP 2024517931 A5 JP2024517931 A5 JP 2024517931A5 JP 2023569823 A JP2023569823 A JP 2023569823A JP 2023569823 A JP2023569823 A JP 2023569823A JP 2024517931 A5 JP2024517931 A5 JP 2024517931A5
- Authority
- JP
- Japan
- Prior art keywords
- tmprss6
- sequence
- seq
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163187150P | 2021-05-11 | 2021-05-11 | |
| US63/187,150 | 2021-05-11 | ||
| PCT/US2022/028595 WO2022240877A1 (en) | 2021-05-11 | 2022-05-10 | Anti-tmprss6 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517931A JP2024517931A (ja) | 2024-04-23 |
| JP2024517931A5 true JP2024517931A5 (cg-RX-API-DMAC7.html) | 2025-05-19 |
Family
ID=81927373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569823A Pending JP2024517931A (ja) | 2021-05-11 | 2022-05-10 | 抗tmprss6抗体及びその使用 |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022240877A1 (en) | 2021-05-11 | 2022-11-17 | Regeneron Pharmaceuticals, Inc. | Anti-tmprss6 antibodies and uses thereof |
| CN120936629A (zh) * | 2023-04-04 | 2025-11-11 | 迪斯克医药公司 | 抗tmprss6抗体及其用途 |
| WO2025245434A1 (en) * | 2024-05-24 | 2025-11-27 | Disc Medicine, Inc. | Compositions and methods for treating myelodysplastic syndromes (mds) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| EP1740946B1 (en) | 2004-04-20 | 2013-11-06 | Genmab A/S | Human monoclonal antibodies against cd20 |
| US8257740B1 (en) | 2011-08-15 | 2012-09-04 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8246995B2 (en) | 2005-05-10 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| ATE537190T1 (de) | 2006-06-02 | 2011-12-15 | Regeneron Pharma | Hochaffine antikörper gegen den humanen il-6- rezeptor |
| GB0916576D0 (en) * | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| TWI682941B (zh) | 2013-02-01 | 2020-01-21 | 美商再生元醫藥公司 | 含嵌合恆定區之抗體 |
| AU2016302768B2 (en) | 2015-07-31 | 2019-08-22 | Medimmune Limited | Methods for treating hepcidin-mediated disorders |
| EP4065607A1 (en) | 2019-11-29 | 2022-10-05 | Kymab Limited | Treatment for physiological iron overload |
| AU2021251087A1 (en) | 2020-04-07 | 2022-12-01 | Mabwell Therapeutics Inc. | Anti-TMPRSS6 antibodies and uses thereof |
| WO2022240877A1 (en) | 2021-05-11 | 2022-11-17 | Regeneron Pharmaceuticals, Inc. | Anti-tmprss6 antibodies and uses thereof |
-
2022
- 2022-05-10 WO PCT/US2022/028595 patent/WO2022240877A1/en not_active Ceased
- 2022-05-10 JP JP2023569823A patent/JP2024517931A/ja active Pending
- 2022-05-10 CA CA3218455A patent/CA3218455A1/en active Pending
- 2022-05-10 US US17/741,234 patent/US12448435B2/en active Active
- 2022-05-10 BR BR112023023558A patent/BR112023023558A2/pt unknown
- 2022-05-10 MA MA63064A patent/MA63064B1/fr unknown
- 2022-05-10 MX MX2023013248A patent/MX2023013248A/es unknown
- 2022-05-10 CN CN202280047837.4A patent/CN117730099A/zh active Pending
- 2022-05-10 EP EP22727583.1A patent/EP4337695A1/en active Pending
- 2022-05-10 KR KR1020237042253A patent/KR20240005894A/ko active Pending
- 2022-05-10 AU AU2022274888A patent/AU2022274888A1/en active Pending
- 2022-05-10 IL IL308375A patent/IL308375A/en unknown
-
2023
- 2023-11-08 CL CL2023003331A patent/CL2023003331A1/es unknown
- 2023-12-04 CO CONC2023/0016777A patent/CO2023016777A2/es unknown
-
2025
- 2025-09-09 US US19/323,318 patent/US20260098084A1/en active Pending